Neurology
Found 73 results
Filters: Keyword is Magnetic Resonance Imaging  [Clear All Filters]
2017
Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.  2017.  Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.. AJR Am J Roentgenol. 209(4):889-894.
Nguyen TD, Spincemaille P, Gauthier SA, Wang Y.  2017.  Rapid whole brain myelin water content mapping without an external water standard at 1.5T.. Magn Reson Imaging. 39:82-88.
Parikh NS, Burch JE, Kamel H, DeAngelis LM, Navi BB.  2017.  Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Primary Brain Tumors.. J Stroke Cerebrovasc Dis. 26(10):2396-2403.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.
Mercuri MA, White H, Oliveira C.  2017.  Vision Loss and Symmetric Basal Ganglia Lesions in Leber Hereditary Optic Neuropathy.. J Neuroophthalmol. 37(4):411-413.
2016
Chiang GC, Pinto S, Comunale JP, Gauthier SA.  2016.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.. J Neuroimaging. 26(3):289-95.
Zhang Y, Gauthier SA, Gupta A, Chen W, Comunale J, Chiang GC-Y, Zhou D, Askin G, Zhu W, Pitt D et al..  2016.  Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.. AJNR Am J Neuroradiol. 37(9):1629-35.
Baradaran H, Omran S, J Chazen L.  2016.  Teaching NeuroImages: Acute crossed cerebellar diaschisis.. Neurology. 86(14):e154-e155.
2015
Vargas WS, Monohan E, Pandya S, Raj A, Vartanian T, Nguyen TD, Rúa SMHurtado, Gauthier SA.  2015.  Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.. Neuroimage Clin. 9:369-75.
Kuceyeski AF, Vargas W, Dayan M, Monohan E, Blackwell C, Raj A, Fujimoto K, Gauthier SA.  2015.  Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.. AJNR Am J Neuroradiol. 36(4):702-9.
Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P et al..  2015.  Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.. J Nutr Health Aging. 19(4):413-23.
Wisnieff C, Ramanan S, Olesik J, Gauthier S, Wang Y, Pitt D.  2015.  Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.. Magn Reson Med. 74(2):564-70.
Bennett JL, Nickerson M, Costello F, Sergott RC, Calkwood JC, Galetta SL, Balcer LJ, Markowitz CE, Vartanian T, Morrow M et al..  2015.  Re-evaluating the treatment of acute optic neuritis.. J Neurol Neurosurg Psychiatry. 86(7):799-808.
Deh K, Nguyen TD, Eskreis-Winkler S, Prince MR, Spincemaille P, Gauthier S, Kovanlikaya I, Zhang Y, Wang Y.  2015.  Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors.. J Magn Reson Imaging. 42(6):1592-600.
2014
Mosconi L, Murray J, Tsui WH, Li Y, Spector N, Goldowsky A, Williams S, Osorio R, McHugh P, Glodzik L et al..  2014.  Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.. Neurology. 82(9):752-60.
Raj A, Pandya S, Shen X, LoCastro E, Nguyen TD, Gauthier SA.  2014.  Multi-compartment T2 relaxometry using a spatially constrained multi-Gaussian model.. PLoS One. 9(6):e98391.
Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei M, Pitt D, Wang Y.  2014.  Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.. Radiology. 271(1):183-92.
2013
Rumah KRashid, Linden J, Fischetti VA, Vartanian T.  2013.  Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.. PLoS One. 8(10):e76359.
2012
Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han X-M, Venkataraman A et al..  2012.  Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.. J Neurol Sci. 315(1-2):49-54.
Perumal JS, Foo F, Cook P, Khan O.  2012.  Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis.. Mult Scler. 18(8):1197-9.
Nguyen TD, Wisnieff C, Cooper MA, Kumar D, Raj A, Spincemaille P, Wang Y, Vartanian T, Gauthier SA.  2012.  T2 prep three-dimensional spiral imaging with efficient whole brain coverage for myelin water quantification at 1.5 tesla.. Magn Reson Med. 67(3):614-21.
2007
Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, de Leon MJ.  2007.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.. Proc Natl Acad Sci U S A. 104(48):19067-72.